`
`NewPage1
`
`http://www.fda.gov/ohms/dockets/ac/cder01.him
`mun-um ”(MV'
`99 captures
`Milmmnnfl
`4 17 >
`w
`‘
`
`
`
`
`I‘Wilu IilIIIIIIiI I I hI I III I III III II 2000 200124Jan01 - 12 Jul 12 200:
`
`APR
`
`JUN
`
`0C7
`
`
`
`
`
`
`
`[Federal Registers ] [FDA Home Page "Dockets Home nge||CBER||CDRI-I]|Og; [fly]
`
`
`
`
`
`
`
`I HvE&,V
`
`4/26
`
`4/26
`
`Pages 1- 100
`3746t1_01.p_(fi
`(10,540)
`
`Pages 101-200
`3746t1_02.p_(fi
`(10,646)
`
`Pages 201-339
`3746t1_03.p1fi
`(19,170)
`
`4/23
`
`4/23
`
`3744t1_01.]fif & m
`
`3744t1.fl
`
`
`
`374mm (388) & html
`(392)
`
`Agenda
`3746a1.p_(fl, mm
`
`Briefing Info.
`3746b1.ht_m
`
`Roster
`
`3746r1_01c0mmittee.1fif,
`ht_m
`3746r1_02quest.pfl, mm
`
`Slides
`
`3746s1.ht_m
`
`Notice of Mtg.
`032301d.ht_m & fl
`
`Briefing Information
`3744mm
`
`Agenda
`3744a1.mf, ht
`
`Roster
`
`3744r1.flf, ht_m
`
`Questions
`3744q1-Ifl. ht_m
`
`Slides
`
`4/24
`
`3744t24fif & ht_m
`
`3744mm
`
`https://web.archi\,e.org/web/20010617210030/h11p://\w~v.fda.g oWohrms/docleIs/ac/cderO’l .htm
`
`3744s 1.1Llf
`Briefing Information
`3744b2.ht_m
`
`
`
`3744r2.pdf, ht_m
`
`Questions
`
`1/7
`
`PAR1018
`
`IPR of US. Patent No. 7,668,730
`Page 1 of 7
`
` PAR1018
`IPR of U.S. Patent No. 7,668,730
` Page 1 of 7
`
`
`
`7/2/2014
`
`01/30
`
`01/30 3719t1_01.pdf(6126)
`3719a 02. df(6374)
`3719t1_03. df (6385)
`3719t1 04.pdf (6428)
`
`New Page 1
`
`3719t1.1f(439)
`
`3719m1.fl,mf
`
`3744q2-mf. ht_m
`
`Slides
`
`3744s2.[fl‘
`
`Briefing Package
`3719b1.htm
`
`Roster
`3719rl.htm
`
`Slides
`3719sl.htm
`
`Agenda
`3719a1.htm
`
`Question
`3719 1.htm
`
`Agenda
`3731a1.d9_e, pif
`
`Slides
`
`373151.hfl
`
`Roster
`
`3731rl.m, pdf
`3731r2.m, fl
`
`Briefing Information
`3731b1.ht_m
`
`Questions
`3731q1.m, Lfl
`
`Agenda
`3676a1.m,;fl
`
`Roster
`3676rl.fl, pdf
`
`Slides
`367651.htm
`
`Briefing Information 3676bl.htm
`
`Anti-Viral Drugs Advisory Committee
`
`2/27
`
`2/27
`
`3731t1 01. df(6394)
`373111_02,pdf (6275)
`373m_03.
`(if (3920)
`
`3731t1.1tf (271)
`
`1/10
`
`3676t1_a.pdf
`3676t1_b. df
`3676t1_c. df
`3676t1_d. df
`
`3676t1.ltf
`
`1/11
`
`3678t1_a.;Ldf
`3678t1_b.1Ldf
`3678t1_c.1Ldf
`
`3578t1.¢f
`
`https://web.archive.orgWeb/20010617210030/http://\/\MAN.fda.g ov/ohrms/dockets/ac/cderm .htm
`
`3676s 1_03. df
`
`Agenda
`3678a] .m, pg
`
`2/7
`
`PAR1018
`
`IPR of US. Patent No. 7,668,730
`Page 2 of 7
`
` PAR1018
`IPR of U.S. Patent No. 7,668,730
` Page 2 of 7
`
`
`
`7/2/2014
`
`New Page 1
`
`3678t1_d.1Ldf
`
`Briefing Information
`3678bl.ht_m
`
`Slides
`
`3678s 1.hfl
`
`To
`
`Arthritis Advisory Committee|
`
`4/20
`
`3740t1_01.1Ldf
`3740t1_02.1Ldf
`3740t1_03.1Ldf
`
`374mm
`
` 4/19
`
`2/7
`
`2/7
`
`3677t1_01.1Ldf(6421)
`3677t1_02.1Ldf (6733)
`3677t1_03.1Ldf (2448)
`
`3677t1 .rtf (561)
`
`Agenda
`3740a1.ht_m & fl
`
`Briefing Information
`3740bl .ht_m
`
`Questions
`3740ql.ht_m & @
`
`Roster
`
`3740r]_01 m & pdf
`3740r1_02 hfl & pdf
`
`Slides
`37405 1.htm
`
`Agenda
`3677a1 -M, pdf
`
`Roster
`
`3677r1_01.m, fl
`
`Guest Roster
`
`3677rl_02.m, pdf
`
`Brie fing lnfo rmation
`3677b1 .ht_m
`
`Questions
`
`3677q1-m, @ Slides
`
`3677s 1.hfl
`
`02/08 3677t2_01.pdf (6774)
`3677t2 02.pdf (6852)
`3677t2_03.pdf (2918)
`
`3677t2.rtf (597)
`
`https://web.archive.org/webl20010617210030/http://\/\MAN.fda.g ov/ohrms/dockets/ac/cderm .htm
`
`Briefing Package
`3677b2.htm
`
`Agenda
`3677a2.doc & fl
`
`Questions
`
`3677qZ_01.d0c & pi
`3677qZ_02.d0c & 11%
`
`Slides
`
`367752.hfl
`
`3/7
`
`PAR1018
`
`IPR of US. Patent No. 7,668,730
`Page 3 of 7
`
` PAR1018
`IPR of U.S. Patent No. 7,668,730
` Page 3 of 7
`
`
`
`7/2/2014
`
`| Top
`
`New Page 1
`
`Cardiovascular and Renal Drugs Advisory Committee
`
`5/24
`
`5/24
`
`5/25
`
`05/11
`
`05/11
`
`Nonprescription Drugs Advisory Committee
`
`Briefing Information
`3749b1.ht_m
`
`Agenda
`3749a1.[fl& ht_m
`
`Questions
`3749ql.pdf & ht_m
`
`Briefing Information
`3749b2.ht_m
`
`Questions
`3749q2.pdf & ht_m
`
`Agenda
`3737al .ht_m, pdf
`
`Planning Agenda
`3737al_planning.ht_m,
`mf
`
`Que stions
`
`3737q1 .ht_m,
`
`iLdf
`
`Brie fing Information
`373 7b1 .htm
`
`m
`
`Agenda
`
`3757a1.ht_m & [fl
`
`Questions
`3757ql .ht_m & pdf
`
`
`
`0-6/070.6/07
`
`Oncologic Drugs Advisory Committee
`
`4/24
`
`4/24
`
`3743t1_01 p_f
`3743t1_02.1Ldf
`
`3743art_f
`
`https://web.archive.orgWeb/20010617210030/http://\/\MAN.fda.g ov/ohrms/dockets/ac/cderm .htm
`
`Briefing Information
`3757b1.ht_m & [fl‘
`
`Agenda
`3743a1.ht_m & pi
`
`4/7
`
`PAR1018
`
`IPR of US. Patent No. 7,668,730
`Page 4 of 7
`
` PAR1018
`IPR of U.S. Patent No. 7,668,730
` Page 4 of 7
`
`
`
`7/2/2014
`
`New Page 1
`
`Briefing Information
`3743b1.ht_m & pd_f
`
`
`3743t1_03.1Ldf
`
`ToE
`
`Peripheral & Central Nervous System Drugs Advisory Committee
`
`6/6
`
`Agenda
`3754a1.1fl, html
`
`Rosters
`
`Members 3754r1_01. df
`html
`
`3724r1_02.m, pdf Briefing Info
`
`3/13
`
`3/13
`
`3724t1.lfl'
`
`3724t1.1f
`
`3724m1.ht_m
`3742m1.pdf
`
`3/14
`
`3724t2.1Ldf
`
`3724t2.fl
`
`3724m2.ht_m
`3724m2.mif
`
`Consultants
`
`3754r1_02.1Ldf, html
`
`Public Hearing
`3754r1_03.pd_f, html
`
`Que stions
`3754q1.pfi, html
`
`Briefing Information
`3754bl .ht_m
`
`Agenda
`3724a1.m, fl
`
`Roster
`
`3724r1_01.m, {fl
`
`Briefing Info
`3724bl.ht_m
`
`Slides
`
`3724sl.hfl
`
`Agenda (DRAFT)
`3724a2.m, pd_f
`
`Roster
`
`3724b2.ht_m
`
`Slides
`
`| Top
`
`Pharmaceutical Science Drugs Advisory Committee
`
`372452.hfl
`
`https://web.archive.orgWeb/20010617210030/http://V\MAN.fda.g ov/ohrms/dockets/ac/cderm .htm
`
`5/7
`
`PAR1018
`
`IPR of US. Patent No. 7,668,730
`Page 5 of 7
`
` PAR1018
`IPR of U.S. Patent No. 7,668,730
` Page 5 of 7
`
`
`
`7/2/2014
`
`New Page 1
`
`3742t1.-df
`
`(10,036)
`
`Non-Clinical Studies Subcommittee
`3742t1.rtf 93 & html — ,
`(100 )
`3742a1.hfl & pdf
`
`df
`
`Psychopharmacologic Drugs Advisory Committee
`
`3685t1.pif, t_
`
`. df
`3685m1 p_
`
`2/15
`
`3685t2.pdf, fl
`
`3685m2.p_
`
`Roster
`
`3742r1.ht_m & pdf
`3742r2.ht_m & [fl
`
`Briefing Info
`3742bl.ht_m & [fl
`
`Notice of Meeting
`98f3032301g.ht_m
`98frx032301g.pdf
`
`Agenda
`3685al.m, fl
`
`Roster
`
`3685r1.m, pdf
`
`Questions
`
`3685q1.ma13d_f
`
`Briefing Info
`3685bl.ht_m
`
`Slides
`
`36855.ht_m
`
`Agenda
`3685a2.m, @
`
`Roster
`
`3685r2.m, mf
`
`Questions
`3685011m, pi
`
`Briefing Info
`3685b2.ht_m
`
`To
`
`5/11
`
`05/11
`
`E 0
`
`Pulmonary-Allergy Drugs Advisory Committee
`
`Agenda
`3737a1.ht_m, pdf
`
`https://web.archive.orgWeb/20010617210030/http://\/\MAN.fda.g ov/ohrms/dockets/ac/cderm .htm
`
`6/7
`
`PAR1018
`
`IPR of US. Patent No. 7,668,730
`Page 6 of 7
`
` PAR1018
`IPR of U.S. Patent No. 7,668,730
` Page 6 of 7
`
`
`
`7/2/2014
`
`New Page 1
`
`Planning Agenda
`3737a1_planning.ht_m,
`1L“
`
`Questions
`3737q1.m_m, w
`
`Briefing Information
`
`M P
`
`etition
`
`https://web.archive.orgWeb/20010617210030/http://\/\MAN.fda.g ov/ohrms/dockets/ac/cderm .htm
`
`7/7
`
`PAR1018
`
`IPR of US. Patent No. 7,668,730
`Page 7 of 7
`
` PAR1018
`IPR of U.S. Patent No. 7,668,730
` Page 7 of 7
`
`